AROI-ESTRO GYN Teaching Course

What do we know about dose to pathological nodes?

Nodal recurrence in pathological nodes after boost

Ramlov et al, Acta Oncol, 2015: limited dose effect for pathological nodes (~55- 65Gy boosts)

Pittsburgh, IJROBP 2015:

0% after boost dose of 55Gy

EMBRACE I:

8% at median FUP of 2 years in patients boosted with a median dose of 59Gy

7